Topiramate
Product Images NDC 0615-8138

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 0615-8138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Topiramate Tablets Glenmark 1)

Chemical structure of the active ingredient topiramate, showing its molecular composition including oxygen, carbon, nitrogen, and sulfur atoms arranged in a complex ring and functional groups.*

FDA Label Image

Image (Topiramate Tablets Glenmark 2)

A Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days for two Topiramate dosage groups: 50 mg/day (solid line) and 400 mg/day (dashed line). The graph compares seizure incidence over time between 234 patients on 50 mg/day and 238 patients on 400 mg/day, with a p-value of 0.0002 indicating statistical significance.*

FDA Label Image

Figure 2 (Topiramate Tablets Glenmark 3)

A bar graph comparing the change from baseline to double-blind phase in average monthly migraine period rate, with standard error bars. The graph shows results for placebo and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 10 and Study 11). Statistical significance is indicated with asterisks for various Topiramate doses compared to placebo.*

FDA Label Image

Image (Topiramate Tablets Glenmark 4)

FDA Label Image

Image (Topiramate Tablets Glenmark 5)

FDA Label Image

Principal Display Panel (25 mg)

Topiramate Tablets USP 25 mg packaging label showing it is manufactured by Glenmark and packaged by Vangard Labs in Glasgow, KY. The label includes multiple small barcode labels, lot number 8138, storage instructions at 20°-25°C, and caution to verify prescription before dispensing. The quantity is noted as 30 tablets, for institutional use only.*

FDA Label Image

Principal Display Panel (50 mg)

Topiramate Tabs USP 50 mg label by NCS HealthCare of KY, LLC dba Vangard Labs, with directions for use showing dates and times, lot number 8139, and quantity of 30 tablets. The label includes storage instructions to keep at controlled room temperature (20°-25°C), cautions to verify prescriptions before dispensing, and notes the product is for institutional use only. Manufacturer is Glenmark. Multiple barcodes and lot/expiration placeholders appear on the sheet.*

FDA Label Image

Principal Display Panel (100 mg)

Topiramate Tabs USP 100 mg packaging label from NCS HealthCare of KY, LLC dba Vangard Labs, showing product name, strength, and dosage form. The label includes lot number 8140, quantity 30 tablets, storage instructions (20°-25°C), and multiple barcodes with corresponding text. The manufacturer is Glenmark, and the package is marked for institutional use only with calibration dates visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.